Award
Delivery Order #SPE2DP26F2949
Delivery Order for Cefazolin Injection Under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$36.10
Ceiling
$36.10
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Mar 09, 2026
Identifier
SPE2DP26F2949
NAICS
424210
This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceutical products. It is linked to a broader definitive pharmaceutical supply contract under an indefinite delivery vehicle, ensuring the distribution of essential medications to federal health agencies. The order specifically procures cefazolin injection, a critical antibiotic used in medical treatments. The contract's significance lies in its role in maintaining a reliable supply chain for vital drugs, supporting public health efforts. The scope includes the delivery of the specified injectable medication within a short-term performance window. This award follows competitive acquisition procedures established under the parent contract and aligns with strategic procurement goals to secure ongoing pharmaceutical needs. The contract performance spans a few weeks, commencing in early 2026, reinforcing timely supply continuity for healthcare requirements.
Description
8511934480!CEFAZOLIN INJECTION